Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 20;12:2641–2651. doi: 10.2147/CMAR.S250171

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Chang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

PIK3CG was a potentially therapeutic target. (A) Images of CLBC patients’ cells in 2D culture. Red arrow indicates single CLBC cell. (B) CLBC patients’ cells were stained with crystal violet. Red arrow indicates single CLBC cell. (C) Relative expression of Claudin1, Claudin3, Claudin4, Claudin7, EpCAM, ALDH1, Vimentin and ZEB in CLBC1 and CLBC2 by qPCR. (D) Relative expression of PIK3CG in CLBC1, CLBC2, Non-CLBC1 and Non-CLBC2 by qPCR. (E) The correlation of PIK3CG expression level and survival rate of patients with breast cancer by the analysis of GSE1456. *P<0.05, **P<0.005, ****P<0.00001.